Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy

Cancer Prevention Research

Volumn 3, Issue 9, 2010, Pages 1093-1103

  Pattani, Kavita Malhotra ^a   Zhang, Zhe ^b   Demokan, Semra ^a   Glazer, Chad ^a   Loyo, Myriam ^a   Goodman, Steven ^b   Sidransky, David ^a   Bermudez, Francisco ^g   Jean Charles, Germain ^h   McCaffrey, Thomas ⁱ   Padhya, Tapan ⁱ   Phelan, Joan ^d   Spivakovsky, Silvia ^d   Bowne, Helen Yoo ^e   Goldberg, Judith D ^f   Rolnitzky, Linda ^f   Robbins, Miriam ^d   Kerr, A Ross ^d   Sirois, David ^d   Califano, Joseph A ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e ST VINCENT S HOSPITAL   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN B RECEPTOR; KINESIN;

ADULT; AGED; ARTICLE; CANCER RISK; DNA METHYLATION; EDNRB GENE; FEMALE; HUMAN; KIF1A GENE; LEUKOPLAKIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SALIVA ANALYSIS; TUMOR SUPPRESSOR GENE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KINESIN; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; RECEPTOR, ENDOTHELIN B; RISK FACTORS; SALIVA; YOUNG ADULT;

EID: 77956414272     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0115     Document Type: Article

References (35)

1. Jemal A, Sieger R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Speight PM, Palmer S, Moles DR, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006;10:1-144, iii-iv.
3. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005;117:605-10. (Pubitemid 41504548)
4. Lallemant B, Evrard A, Combescure C, et al. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer 2009;9:370.
5. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 2000;36:525-8.
6. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-42.
7. El-Naggar AK, Mao L, Staerkel G, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 2001;3:164-70.
8. Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 1996;56:722-7. (Pubitemid 126532425)
9. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
10. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006;7:77-82.
11. Palmisano WA, Crume KP, Grimes MJ, et al. Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. Cancer Res 2003;63:4620-5.
12. Carvalho AL, Jeronimo C, Kim MM, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14:97-107.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
14. Harden SV, Tokumaru Y, Westra WH, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 2003;9:1370-5. (Pubitemid 36418388)
15. Kramer IR, Pindborg JJ, Bezroukov V, Infirri JS, World Health Organization. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. Community Dent Oral Epidemiol 1980;8:1-26.
16. Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Muller SC, von Rucker A. Prognostic value of CpG island hypermethylation at PTGS2, RAR-β, EDNRB, other gene loci in patients undergoing radical prostatectomy. Eur Urol 2007;51:665-74, discussion 74.
17. Bastian PJ, Palapattu GS, Yegnasubramanian S, et al. CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer. J Urol 2008;179:529-34, discussion 34-5.
18. Ellinger J, Bastian PJ, Jurgan T, et al. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 2008;71:161-7.
19. Jeronimo C, Henrique R, Campos PF, et al. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 2003;56:52-5. (Pubitemid 36132475)
20. Woodson K, Gillespie J, Hanson J, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 2004;60:25-31.
21. Nelson JB, Lee WH, Nguyen SH, et al. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 1997;57:35-7.
22. Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004;64:1975-86.
23. Chen SC, Lin CY, Chen YH, et al. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan. Oncol Rep 2006;15:167-72.
24. Friedrich MG, Weisenberger DJ, Cheng JC, et al. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res 2004;10:7457-65.
25. Yates DR, Rehman I, Abbod MF, et al. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007;13:2046-53.
26. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep 2006;15:507-11.
27. Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 2002;98:651-5. (Pubitemid 34225614)
28. Hsiao PC, Liu MC, Chen LM, et al. Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan. Chin J Physiol 2008;51:27-31.
29. Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 2009;22:55-61.
30. Ostrow KL, Park HL, Hoque MO, et al. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res 2009;15:1184-91.
31. Ahluwalia KP, Yellowitz JA, Goodman HS, Horowitz AM. An assessment of oral cancer prevention curricula in U. S. medical schools. J Cancer Educ 1998;13:90-5.
32. Baysac MA, Horowitz AM, Ma DS. Oral cancer information in health education textbooks. J Cancer Educ 2004;19:12-6.
33. Day TA, Chi A, Neville B, Hebert JR. Prevention of head and neck cancer. Curr Oncol Rep 2005;7:145-53.
34. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008;44:10-22.
35. Thomson PJ. Field change and oral cancer: new evidence for wide-spread carcinogenesis? Int J Oral Maxillofac Surg 2002;31:262-6.